Predictive Value of the Endothelial Activation and Stress Index (EASIX) for Engraftment Syndrome After Autologous Hematopoietic Stem Cell Transplantation in Multiple Myeloma and Lymphoma Patients (EASIX and Engraftment Syndrome in ASCT)
Hematological Oncology · 2026-11 · 44 (6)
DOI: 10.1002/hon.70294 ↗At a glance
Journal article in Hematological Oncology, published online on 2026-11-20. Written by Tuğçe Şevval Yıldız and 6 co-authors. 11 references.
Abstract (original language)
Engraftment syndrome (ES) is a clinically challenging, hyper‐inflammatory complication following autologous hematopoietic stem cell transplantation (ASCT). The Endothelial Activation and Stress Index (EASIX) has emerged as a reliable biomarker for endothelial dysfunction and non‐relapse mortality in allogeneic transplantation; however, its predictive utility for ES in the autologous setting has not been fully established. This study evaluated the incidence, risk factors, and clinical outcomes of ES in patients with multiple myeloma (MM) and lymphoma, focusing on the dynamic predictive value of peritransplant EASIX scores. We retrospectively analyzed 303 adult patients with MM or lymphoma who underwent ASCT at a single center between 2015 and 2025. ES was diagnosed using the Maiolino criteria. EASIX was assessed at four time points: before conditioning, on the day of transplantation (day 0), and on days +7 and +14. The incidence of ES was 14.2%. Demographic characteristics, conditioning regimens, and infused cell doses did not differ significantly between patients with and without ES. Pre‐conditioning EASIX scores were comparable between groups; however, the median EASIX score on day 0 was significantly higher in patients who subsequently developed ES (2.35 vs. 1.46; p = 0.019). In univariable logistic regression, log‐transformed EASIX on day 0 was associated with ES development (OR 1.399, 95% CI 1.033–1.894), with an AUC of 0.612 (95% CI 0.524–0.700). Patients with ES had a significantly higher rate of severe (grade 3–4) diarrhea (48.8% vs. 23.1%) and prolonged post‐transplant antibiotic therapy (median 12 vs. 8 days). No statistically significant differences were observed between groups in progression‐free or overall survival. In conclusion, engraftment syndrome significantly increases early post‐transplant gastrointestinal toxicity and supportive care requirements without adversely affecting long‐term survival outcomes. While log‐transformed EASIX on day 0 correlates with ES risk, its standalone discriminative performance remains modest. EASIX is best utilized as an integrated component within broader, multiparametric risk‐stratification models rather than as an isolated predictor.
Cite
APA
Yıldız, T. Ş., Ceran, A. A., Sarı, İ. E., Yeğin, Z. A., Şeyhanlı, A., Yağcı, A. M., & Özkurt, Z. N. (2026). Predictive Value of the Endothelial Activation and Stress Index (EASIX) for Engraftment Syndrome After Autologous Hematopoietic Stem Cell Transplantation in Multiple Myeloma and Lymphoma Patients (EASIX and Engraftment Syndrome in ASCT). Hematological Oncology, 44(6). https://doi.org/10.1002/hon.70294
Vancouver
Yıldız TŞ, Ceran AA, Sarı İE, Yeğin ZA, Şeyhanlı A, Yağcı AM, et al. Predictive Value of the Endothelial Activation and Stress Index (EASIX) for Engraftment Syndrome After Autologous Hematopoietic Stem Cell Transplantation in Multiple Myeloma and Lymphoma Patients (EASIX and Engraftment Syndrome in ASCT). Hematological Oncology. 2026;44(6). doi:10.1002/hon.70294
BibTeX
@article{Yldz2026,
author = {Yıldız, Tuğçe Şevval and Ceran, Ahmet Alparslan and Sarı, İrem Eser and Yeğin, Zeynep Arzu and Şeyhanlı, Ahmet and Yağcı, Abdullah Münci and Özkurt, Zübeyde Nur},
title = {Predictive Value of the Endothelial Activation and Stress Index (EASIX) for Engraftment Syndrome After Autologous Hematopoietic Stem Cell Transplantation in Multiple Myeloma and Lymphoma Patients (EASIX and Engraftment Syndrome in ASCT)},
journal = {Hematological Oncology},
year = {2026},
volume = {44},
number = {6},
doi = {10.1002/hon.70294}
}
EUVIMED